Today, $NTLA announced Q1 2021 financial results and plan to report initial clinical data from its Phase 1 study for #ATTR mid-2021. Full release here: https://t.co/YIsSOIoYEM #genomeediting #CRISPR https://t.co/BAdyAHGY7c